Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| METABASIS THERAPEUTICS INC | 250,000 | reported | 02 Mar 2009 | tx 1+250,000 |
| PROTHENA CORP PUBLIC LTD CO | 230,000 | reported | 03 Mar 2026 | tx 86+2,152,537−825,995 |
| ProNAi Therapeutics Inc | 30,000 | reported | 11 Jun 2019 | tx 4+157,670 |
| Somaxon Pharmaceuticals, Inc. | 0 | reported | 06 Mar 2013 | tx 14+470,702−49,431 |
| Rain Therapeutics Inc. | 0 | reported | 26 Jan 2024 | tx 6+55,000−111,486 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 230,000 | 0.00 USD | deriv |
| 28 Jul 2025 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 95,000 | 0.00 USD | |
| 05 Mar 2025 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 107,500 | 0.00 USD | deriv |
| 08 Apr 2020 | OTHER | PROTHENA CORP PUBLIC LTD CO | 995 | 0.00 USD | |
| 27 Feb 2024 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 85,000 | 0.00 USD | deriv |
| 26 Jan 2024 | OTHER | Rain Therapeutics Inc. | 42,596 | — | deriv |
| 26 Jan 2024 | OTHER | Rain Therapeutics Inc. | 13,890 | — | deriv |
| 26 Jan 2024 | OTHER | Rain Therapeutics Inc. | 35,000 | — | deriv |
| 26 Jan 2024 | OTHER | Rain Therapeutics Inc. | 20,000 | — | deriv |
| 09 Aug 2023 | GRANT_AWARD | Rain Therapeutics Inc. | 35,000 | 0.00 USD | deriv |
| 17 May 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 50,000 | 22.85 USD | |
| 17 May 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 45,000 | 29.81 USD | |
| 17 May 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 14,001 | 72.66 USD | |
| 17 May 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 100 | 76.04 USD | |
| 17 May 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 34,640 | 73.54 USD | |
| 17 May 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 37,044 | 74.55 USD | |
| 17 May 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 9,215 | 75.44 USD | |
| 17 May 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 45,000 | 0.00 USD | deriv |
| 17 May 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 50,000 | 0.00 USD | deriv |
| 15 Mar 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 10,000 | 6.73 USD | |
| 15 Mar 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 5,198 | 48.68 USD | |
| 15 Mar 2023 | SALE | PROTHENA CORP PUBLIC LTD CO | 4,802 | 48.16 USD | |
| 15 Mar 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 10,000 | 0.00 USD | deriv |
| 02 Mar 2023 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 48,000 | 0.00 USD | deriv |
| 15 Feb 2023 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 10,000 | 6.73 USD |
2 purchases reported after at least 12 months of silence — most recent on 09 Mar 2017.